A new market study, titled “Global Diabetes Drug Therapy Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Diabetes Drug Therapy market status and forecast, categorizes the global Diabetes Drug Therapy market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
The global Diabetes Drug Therapy market is valued at 10000 million US$ in 2017 and will reach 21400 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.
The major manufacturers covered in this report
Bristol Myers Squibb
Eli Lilly and Company
Novartis International AG
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Type 1 Diabetes
Type 2 Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
The study objectives of this report are:
To analyze and study the global Diabetes Drug Therapy sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Diabetes Drug Therapy manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Diabetes Drug Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Diabetes Drug Therapy Manufacturers
Diabetes Drug Therapy Distributors/Traders/Wholesalers
Diabetes Drug Therapy Subcomponent Manufacturers
Table of Contents
1 Diabetes Drug Therapy Market Overview
2 Global Diabetes Drug Therapy Market Competition by Manufacturers
3 Global Diabetes Drug Therapy Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Diabetes Drug Therapy Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Diabetes Drug Therapy Production, Revenue (Value), Price Trend by Type
6 Global Diabetes Drug Therapy Market Analysis by Application
7 Global Diabetes Drug Therapy Manufacturers Profiles/Analysis
8 Diabetes Drug Therapy Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Diabetes Drug Therapy Market Forecast (2018-2025)
13 Research Findings and Conclusion
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)